Davies, Kay E.

Utrophin–dystrophin-deficient mice as a model for Duchenne muscular dystrophy

Deconinck, A. E., Rafael, J. A., Skinner, J. A., Brown, S. C., Potter, A. C., Metzinger, L., Watt, D. J., Dickson, J. G., Tinsley, J. M., & Davies, K. E. (1997) · Cell

Muscle Physiology and DisordersNeurogenetic and Muscular Disorders Research

Cited by 752

A functional genetic link between distinct developmental language disorders

Vernes, S. C., Newbury, D. F., Abrahams, B. S., Winchester, L., Nicod, J., Groszer, M., Alarcón, M., Oliver, P. L., Davies, K. E., Geschwind, D. H., et al. (2008) · New England Journal of Medicine

Language Development and DisordersGenetics and Neurodevelopmental Disorders

Cited by 676

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin

England, S. B., Nicholson, L. V. B., Johnson, M. A., Forrest, S. M., Love, D. R., Zubrzycka-Gaarn, E. E., Bulman, D. E., Harris, J. B., & Davies, K. E. (1990) · Nature

Muscle Physiology and DisordersNeurogenetic and Muscular Disorders Research

Cited by 623

Therapies for rare diseases: therapeutic modalities, progress and challenges ahead

Tambuyzer, E., Vandendriessche, B., Austin, C. P., Brooks, P. J., Larsson, K., Miller Needleman, K. I., Valentine, J., Davies, K., Groft, S. C., Preti, R., et al. (2020) · Nature Reviews Drug Discovery

Pharmaceutical Economics and PolicyGenomics and Rare Diseases

Cited by 357

Pharmacological strategies for muscular dystrophy

Khurana, T. S., & Davies, K. E. (2003) · Nature Reviews Drug Discovery

Muscle Physiology and DisordersNeurogenetic and Muscular Disorders Research

Cited by 225

Localization of the mdx mutation within the mouse dystrophin gene

Ryder‐Cook, A. S., Sicinski, P., Thomas, K., Davies, K. E., Worton, R. G., Barnard, E. A., Darlison, M. G., & Barnard, P. J. (1988) · The EMBO Journal

Muscle Physiology and DisordersGenomic variations and chromosomal abnormalities

Cited by 139

Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer

Cerletti, M., Negri, T., Cozzi, F., Colpo, R., Andreetta, F., Croci, D., Davies, K. E., Cornelio, F., Pozza, O., Karpati, G., et al. (2003) · Gene Therapy

Muscle Physiology and DisordersVirus-based gene therapy research

Cited by 126

The role of utrophin in the potential therapy of Duchenne muscular dystrophy

Perkins, K. J., & Davies, K. E. (2002) · Neuromuscular Disorders

Muscle Physiology and DisordersNeurogenetic and Muscular Disorders Research

Cited by 71

Origins of the fragile X syndrome mutation.

Hirst, M. C., Knight, S. J., Christodoulou, Z., Grewal, P. K., Fryns, J. P., & Davies, K. E. (1993) · Journal of Medical Genetics

Genetics and Neurodevelopmental DisordersGenomics and Rare Diseases

Cited by 53

The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery

Eckenfelder, A., Tordo, J., Babbs, A., Davies, K. E., Goyenvalle, A., & Danos, O. (2012) · Molecular Therapy - Nucleic Acids

RNA Interference and Gene DeliveryRNA Research and Splicing

Cited by 17

Verifying nomenclature of DNA variants in submitted manuscripts: Guidance for journals

Higgins, J., Dalgleish, R., Dunnen, J. T., Barsh, G., Freeman, P. J., Cooper, D. N., Cullinan, S., Davies, K. E., Dorkins, H., Gong, L., et al. (2021) · Human Mutation

Academic Writing and PublishingGenomics and Rare Diseases

Cited by 13

Surrogate gene therapy for muscular dystrophy

Davies, K. E., & Chamberlain, J. S. (2019) · Nature Medicine

Muscle Physiology and DisordersVirus-based gene therapy research

Cited by 11